亚太药业9.96%涨停，总市值54.88亿元

Group 1 - The core point of the news is that Asia-Pacific Pharmaceutical experienced a significant stock price increase, reaching a limit up of 9.96% on August 1, with a trading price of 7.36 yuan per share and a total market capitalization of 5.488 billion yuan [1] - The company is located in Shaoxing, Zhejiang Province, and operates as a comprehensive pharmaceutical enterprise engaged in research, production, and sales, with a product range that includes chemical drug formulations, raw materials, and drug development [1] - Asia-Pacific Pharmaceutical holds 106 drug approval numbers and over 20 technology patents, having passed the national GMP certification, with products distributed across multiple provinces in China and exported overseas [1] Group 2 - As of March 31, the number of shareholders for Asia-Pacific Pharmaceutical was 60,800, with an average of 12,200 circulating shares per person [2] - For the first quarter of 2025, the company reported operating revenue of 64.55 million yuan, a year-on-year decrease of 42.73%, and a net profit attributable to shareholders of -7.80 million yuan, reflecting a year-on-year decrease of 160.25% [2]